VIKING THERAPEUTICS INC's ticker is VKTX and the CUSIP is 92686J106. A total of 135 filers reported holding VIKING THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 0.30 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $117,652 | -99.2% | 10,628 | -98.8% | 0.00% | -100.0% |
Q1 2023 | $14,927,191 | +67.7% | 896,528 | -5.3% | 0.04% | +52.0% |
Q4 2022 | $8,902,063 | +261.0% | 947,028 | +4.5% | 0.02% | +257.1% |
Q3 2022 | $2,466,000 | -23.9% | 906,628 | -19.1% | 0.01% | -22.2% |
Q2 2022 | $3,240,000 | -2.5% | 1,121,028 | +1.2% | 0.01% | 0.0% |
Q1 2022 | $3,324,000 | -17.7% | 1,108,028 | +26.1% | 0.01% | -10.0% |
Q4 2021 | $4,041,000 | -31.5% | 878,428 | -6.4% | 0.01% | -33.3% |
Q3 2021 | $5,896,000 | 0.0% | 938,828 | -4.6% | 0.02% | -6.2% |
Q2 2021 | $5,896,000 | -9.2% | 984,228 | -4.1% | 0.02% | -11.1% |
Q1 2021 | $6,491,000 | +148.7% | 1,026,228 | +121.4% | 0.02% | +157.1% |
Q4 2020 | $2,610,000 | +450.6% | 463,528 | +468.6% | 0.01% | +600.0% |
Q3 2020 | $474,000 | +66.3% | 81,528 | +106.4% | 0.00% | 0.0% |
Q2 2020 | $285,000 | +176.7% | 39,500 | +194.8% | 0.00% | – |
Q4 2018 | $103,000 | -81.6% | 13,400 | -58.4% | 0.00% | -100.0% |
Q3 2018 | $561,000 | +143.9% | 32,200 | +33.1% | 0.00% | 0.0% |
Q2 2018 | $230,000 | +180.5% | 24,200 | +28.7% | 0.00% | – |
Q1 2018 | $82,000 | – | 18,800 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
DAFNA Capital Management LLC | 450,900 | $2,624,000 | 0.85% |
Sio Capital Management, LLC | 709,780 | $4,131,000 | 0.82% |
KNOTT DAVID M | 218,102 | $1,269,000 | 0.74% |
ArrowMark Colorado Holdings LLC | 7,988,635 | $46,494,000 | 0.44% |
Park West Asset Management LLC | 1,457,507 | $8,483,000 | 0.33% |
VIRTUS ALTERNATIVE INVESTMENT ADVISERS, INC. | 1,657 | $10,000 | 0.18% |
Virtus ETF Advisers LLC | 42,507 | $247,000 | 0.13% |
Cornerstone Capital, Inc. | 125,465 | $730,000 | 0.10% |
L & S Advisors Inc | 114,988 | $669,000 | 0.09% |
EXANE DERIVATIVES | 44,877 | $261,170,000 | 0.08% |